RedChip Companies
|
Weekly Newsletter
|
|
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma
|
Soligenix (Nasdaq: SNGX), late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive clinical results from a compatibility study evaluating HyBryte™ (synthetic hypericin sodium) in the treatment of cutaneous T-cell lymphoma (CTCL) using the commercially ready Daavlin Series 7 visible light device, which recently received 510(k) clearance from U.S. Food and Drug Administration (FDA).
For more information, visit www.soligenix.com
|
Orlando Dreamers, a RedChip client, Files Formal Application to Work with Orange County Government on Proposed $1.7 Billion Major League Baseball Stadium
Orlando City Baseball Dreamers, LLC, a RedChip client, announced the recent filing of a formal application with the Orange County Tourist Development Tax task force to partially fund a new Major League Baseball stadium and associated parking garages, that will create approximately 25,000 permanent jobs and generate an estimated $1.16 billion in annual economic impact for Orange County.
|
Lantern Pharma Develops Top-Ranked AI Algorithms to Predict the Blood-Brain-Barrier Permeability of Any Compound
Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has developed highly-accurate and industry-leading AI algorithms to predict the ability of a drug or compound to pass the blood-brain-barrier (BBB), a highly selective border that can prevent drugs from entering brain tissues.
|
|
|
Sidus Space Partners with Lulav Space to Offer Solution for Guidance Navigation and Control on Lunar Missions
Sidus Space (Nasdaq: SIDU), a Space and Defense-as-a-Service satellite company focused on mission-critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support, is pleased to announce it has signed a memorandum of understanding with Lulav Space, an Israeli robotics company specializing in space applications, to cooperate in the US market by providing a complete guidance navigation and control (GN&C) solution for both lunar satellite and lunar lander missions.
|
KWESST Receives Notice of Contract Award for Approximately $20M over Five Years for Software Systems Development for Canadian Department of National Defence
KWESST Microsystems (Nasdaq: KWE) announced that it received notification of contract award under a joint venture with two other defence industry partners, to perform software systems engineering work for the Canadian Department of National Defence ("DND"). The contract component for KWESST is valued at a minimum of $4M annually for a five-year initial contract followed by five, one-year option years. All amounts in Canadian dollars.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: BFRG - BullFrog AI |
4:15pm Eastern |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
NYSE American: ZOM - Zomedica |
4:15pm Eastern |
Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. |
|
|
|
|
NASDAQ: KWE - KWESST Micro Systems |
4:15pm Eastern |
KWESST Micro Systems develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. |
|
|
|
|
NASDAQ: BIVI - BioVie |
4:15pm Eastern |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NYSE American: GNS - Genius Group |
11:00am Eastern |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: SNGX - Soligenix |
4:15pm Eastern |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
NASDAQ: LTRN - Lantern Pharma |
4:15pm Eastern |
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
11:00am Eastern |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
4:15pm Eastern |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Archive Events |
|
|
|
NASDAQ: UNCY - Unicycive Therapeutics |
Meeting Duration 28 minutes |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 32 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 30 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 38 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
Meeting Duration 37 minutes |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
Meeting Duration 44 minutes |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
Meeting Duration 40 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: DGLY - Digital Ally |
Meeting Duration 31 minutes |
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
Meeting Duration 47 minutes |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
Meeting Duration 24 minutes |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
Lesson of the Week
Dollar cost averaging is a great way to accumulate long-term positions.
|
|
|
MidSouth Week in Review
The Fed raised interest rates by a quarter of a percentage point, for the 10th rate hike and a 16-year high, but suggested it may pause on more hikes.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|